Search All UT System Experts

A Phase II study with cetuximab and radiation therapy for patients with surgically resectable esophageal and GE junction carcinomas: Hoosier oncology group G05-92

Carlos R. Becerra, Nasser Hanna, Andrew David Mccollum, Naftali Becharm, Robert D. Timmerman, Michael Dimaio, Kenneth A. Kesler, Menggang Yu, Tong Yan, Hak Choy

Research output: Contribution to journal › Article › peer-review

19 Scopus citations

Fingerprint

Dive into the research topics of 'A Phase II study with cetuximab and radiation therapy for patients with surgically resectable esophageal and GE junction carcinomas: Hoosier oncology group G05-92'. Together they form a unique fingerprint.

Medicine & Life Sciences